Caption Management, LLC Gilead Sciences, Inc. Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $147,880 - $161,340	2,000 Added 36.36%	7,500 $562,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $138,718 - $158,227	-1,825 Reduced 24.91%	5,500 $423,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $566,295 - $645,186	7,325 New	7,325 $607,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $8.25 Million - $9.02 Million	130,000 New	130,000 $8.95 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.25 Million - $1.6 Million	-20,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.25 Million - $1.38 Million	20,000 New	20,000 $1.27 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.